DOI QR코드

DOI QR Code

Comparative Efficacy of Ivermectin and Levamisole for Reduction of Migrating and Encapsulated Larvae of Baylisascaris transfuga in Mice

  • Fu, Yan (Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University) ;
  • Nie, Hua-Ming (Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University) ;
  • Niu, Li-Li (Chengdu Zoological Garden) ;
  • Xie, Yue (Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University) ;
  • Deng, Jia-Bo (Chengdu Zoological Garden) ;
  • Wang, Qiang (Chengdu Zoological Garden) ;
  • Yang, Guang-You (Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University) ;
  • Gu, Xiao-Bin (Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University) ;
  • Wang, Shu-Xian (Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural University)
  • Received : 2010.12.28
  • Accepted : 2011.01.30
  • Published : 2011.06.30

Abstract

The comparative efficacy of 2 anthelmintics (ivermectin and levamisole) against Baylisascaris transfuga migrating and encapsulated larvae was studied in mice. A total of 60 BALB/c mice inoculated each with about 1,000 embryonated B. transfuga eggs were equally divided into 6 groups (A-F) randomly. Mice of groups A and B were treated with ivermectin and levamisole, respectively, on day 3 post-infection (PI). Mice of groups A-C were killed on day 13 PI. Similarly, groups D and E were treated with ivermectin and levamisole, respectively, on day 14 PI, and all mice of groups D-F were treated on day 24 PI. The groups C and F were controls. Microexamination was conducted to count the larvae recovering from each mouse. The percentages of reduction in the number of migrating larvae recovered from group A (ivermectin) and B (levamisole) were 88.3% and 81.1%, respectively. In addition, the reduction in encapsulated larvae counts achieved by ivermectin (group D) and levamisole (group E) was 75.0% and 49.2%, respectively. The results suggested that, to a certain extent, both anthelmintics appeared to be more effective against migrating larvae than encapsulated larvae. However, in the incipient stage of infection, ivermectin may be more competent than levamisole as a larvicidal drug for B. transfuga.

Keywords

References

  1. Papini R, Casarosa L. A report on the pathology of Baylisascaris transfuga (Ascarididae: Nematoda) for mice. Rev Med Vet 1994; 145: 949-952.
  2. Sprent JF. Observations relating to the diagnosis of visceral larval migrans. In Corradetti A ed, Proc First Int Congr Parasitol 1964; 2: 802-803.
  3. Papini R, Malloggi M, Casarosa L. Parenteral infection in mice with Baylisascaris transfuga (Nematoda: Ascaridae) infective eggs. Folia Parasitol 1995; 42: 69-71.
  4. Kazacos KR. Baylisascaris procyonis and related species. In Samuel WM, Kocan AA, Pybus MJ ed, Parasitic Diseases of Wild Mammals. 2nd ed. Ames, Iowa, USA. Iowa State University. 2001, p 301-364.
  5. Papini R, Cavicchio P, Casarosa L. Experimental infection in chickens with larvae of Baylisascaris transfuga (Nematoda: Ascaridae). Folia Parasitol 1993; 40: 141-143.
  6. Bauer C, Gey A. Efficacy of six anthelmintics against luminal stages of Baylisascaris procyonis in naturally infected raccoons (Procyon lator). Vet Parasitol 1995; 60: 155-159. https://doi.org/10.1016/0304-4017(94)00774-7
  7. Wise ME, Sorvillo FJ, Shafir SC, Ash LR, Berlin OG. Severe and fatal central nervous system disease in humans caused by Baylisascaris procyonis, the common roundworm of raccoons: a review of current literature. Microbes Infect 2005; 7: 317-323. https://doi.org/10.1016/j.micinf.2004.12.005
  8. Papini R, Lo Piccolo MS, Casarosa L. Effect of ivermectin on the migration of Baylisascaris transfuga larvae into the brain of mice. Folia Parasitol 1996; 43: 157-158.
  9. Ottesen EA, Ismail MM, Horton J. The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitol Today 1999; 15: 382-386. https://doi.org/10.1016/S0169-4758(99)01486-6
  10. Feng XP, Hayashi J, Beech RN, Prichard RK. Study of the nematode putative GABA type-A receptor subunits: evidence for modulation by ivermectin. J Neurochem 2002; 83: 870-878. https://doi.org/10.1046/j.1471-4159.2002.01199.x
  11. Cho S, Egami M, Ohnuki H, Saito Y, Chinone S, Shichinohe K, Suganuma M, Akao N. Migration behaviour and pathogenesis of five ascarid nematode species in the Mongolian gerbil Meriones unguiculatus. J Helminthol 2007; 81: 43-47.
  12. Gonzalez Canga A, Sahagun Prieto AM, Jose Diez Liebana M, Martinez NF, Vega MS, Vieitez JJ. The pharmacokinetics and metabolism of ivermectin in domestic animal species. Vet J 2009; 179: 25-37. https://doi.org/10.1016/j.tvjl.2007.07.011
  13. Campbell WC, Benz GW. Ivermectin: a review of efficacy and safety. J Vet Pharmacol Ther 1984; 7: 1-16. https://doi.org/10.1111/j.1365-2885.1984.tb00872.x
  14. Shoop WL, Haines HW, Michael BF, Eary CH. Mutual resistance to avermectins and milbermycins: oral activity of ivermectin and moxidectin against ivermectin-resistance and susceptible nematodes. Vet Rec 1993; 133: 445-447. https://doi.org/10.1136/vr.133.18.445
  15. Goldstein G. Mode of action of levamisole. J Rheumatol Suppl 1978; 4: 143-148.
  16. Bennett DG. Clinical pharmacology of ivermectin. J Am Vet Med Assoc 1986; 189: 100-104.
  17. Lin LC, Tsai TH. Pharmacokinetics and brain distribution of unbound levamisole in the anesthetized rats using microdialysis and microbore column liquid chromatography. Anal Chim Acta 2006; 569: 145-150. https://doi.org/10.1016/j.aca.2006.03.068
  18. Hirata M, Fukuma T. Cytokine regulation in experimentally-induced Schistosoma japonicum egg granuloma formation. Parasitol Int 2003; 52: 341-349. https://doi.org/10.1016/S1383-5769(03)00050-3
  19. Co DO, Hogan LH, II-Kim S, Sandor M. T cell contributions to the different phases of granuloma formation. Immunol Lett 2004; 92: 135-142. https://doi.org/10.1016/j.imlet.2003.11.023
  20. Sprent JF. On the migratory behavior of the larvae of various Ascaris species in white mice: I. Distribution of larvae in tissues. J Infect Dis 1952; 90: 165-176. https://doi.org/10.1093/infdis/90.2.165
  21. Sugane K, Oshima T. Interrelationship of eosinophilia and IgE antibody production to larval ES antigen in Toxocara canis infected mice. Parasite Immunol 1984; 6: 409-420. https://doi.org/10.1111/j.1365-3024.1984.tb00812.x
  22. Papini R, Casarosa L. Observations on the infectivity of Baylisascaris transfuga eggs for mice. Vet Parasitol 1994; 51: 283-288. https://doi.org/10.1016/0304-4017(94)90166-X

Cited by

  1. Cloning and characterization of a novel sigma-like glutathione S-transferase from the giant panda parasitic nematode, Baylisascaris schroederi vol.8, pp.1, 2011, https://doi.org/10.1186/s13071-014-0629-9
  2. Update on Baylisascariasis, a Highly Pathogenic Zoonotic Infection vol.29, pp.2, 2016, https://doi.org/10.1128/cmr.00044-15
  3. Beyond the raccoon roundworm: The natural history of non-raccoon Baylisascaris species in the New World vol.6, pp.2, 2011, https://doi.org/10.1016/j.ijppaw.2017.04.003